Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.72 |
| ▸ | TSHR | P16473 | 1/20 | 0.72 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.67 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.67 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.67 |
| ▸ | CDC25B | P30305 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | NPY1R | P25929 | 1/20 | 0.53 |
| ▸ | NPY2R | P49146 | 1/20 | 0.53 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.51 |
| ▸ | CDC25A | P30304 | 1/20 | 0.50 |
| ▸ | CDC25C | P30307 | 1/20 | 0.50 |
| ▸ | CACNA1B | Q00975 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28883856 | 0.88 | ALDH1A1 (0.73) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL29268479 | 0.85 | ADRB2 (0.64) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL27541872 | 0.84 | ADRB2 (0.60) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL42787 | 0.84 | ALDH1A1 (1.00) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL29387332 | 0.84 | ALDH1A1 (1.00) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL8144263 | 0.84 | ALDH1A1 (1.00) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL12019109 | 0.84 | ADRB2 (0.59) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL14461611 | 0.83 | ADRB2 (0.56) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL162635 | 0.83 | ALDH1A1 (0.61) | ALDH1A1TSHRADRB2ADRB1ADRB3 | |
| SCHEMBL6909094 | 0.83 | ALDH1A1 (0.61) | ALDH1A1TSHRADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111588514-B | Method for preparing artificial cornea central part through photocatalysis | 深圳华明生物科技有限公司 | 2023-03-31 | — | — | CN | claimed |
| CN-111320732-B | Amphiphilic block copolymer with near-infrared thermal responsiveness and preparation and application thereof | 苏州大学 | 2023-02-10 | — | — | CN | claimed |
| CN-113527642-B | Polyester-based brush polymer electrolyte and preparation and application thereof | 华中科技大学 | 2022-04-12 | — | — | CN | claimed |
| CN-106543306-A | For the catalytic component of olefinic polymerization, catalyst and preparation method thereof | 中国石油化工股份有限公司 | 2017-03-29 | — | — | CN | claimed |
| CN-106478845-A | For the catalytic component of olefinic polymerization, catalyst and preparation method thereof | 中国石油化工股份有限公司 | 2017-03-08 | — | — | CN | claimed |
| US-20240067651-A1 | PRODRUGS OF MYELOPEROXIDASE INHIBITORS | BIOHAVEN THERAPEUTICS LTD. | 2024-02-29 | — | — | US | disclosed |
| US-20240067651-A1 | PRODRUGS OF MYELOPEROXIDASE INHIBITORS | BIOHAVEN THERAPEUTICS LTD. | 2024-02-29 | — | — | US | disclosed |
| EP-3661900-B1 | IRON-CATALYZED TRANSFER HYDROGENATION OF ESTERS TO ALCOHOLS | EASTMAN CHEM CO (US) | 2023-11-01 | — | — | EP | disclosed |
| CN-111588514-B | Method for preparing artificial cornea central part through photocatalysis | 深圳华明生物科技有限公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-111320732-B | Amphiphilic block copolymer with near-infrared thermal responsiveness and preparation and application thereof | 苏州大学 | 2023-02-10 | — | — | CN | disclosed |
| US-11377580-B2 | Methods for in situ formation of high glass transition temperature polymers | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2022-07-05 | — | — | US | disclosed |
| CN-113527642-B | Polyester-based brush polymer electrolyte and preparation and application thereof | 华中科技大学 | 2022-04-12 | — | — | CN | disclosed |
| EP-0173470-A2 | Catalyst component for polymerization of olefins | Tonen Corporation (JP) | 1986-03-05 | — | — | EP | disclosed |
| EP-0171155-A1 | Catalyst component for polymerization of olefins | Tonen Corporation (JP) | 1986-02-12 | — | — | EP | disclosed |
| EP-0171200-A2 | Catalyst component for polymerization of olefins | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1986-02-12 | — | — | EP | disclosed |
| US-4565798-A | COORDINATION CATALYSTS, TITANIUM, MAGNESIUM, SILICON COMPOUND | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1986-01-21 | — | — | US | disclosed |
| EP-0157472-A1 | Process for polymerization of olefins | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1985-10-09 | — | — | EP | disclosed |
| EP-0156512-A1 | Process for preparing catalyst component for polymerization of olefins | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1985-10-02 | — | — | EP | disclosed |
| EP-0147053-A1 | A catalyst and a process for polymerization of olefins | Tonen Corporation (JP) | 1985-07-03 | — | — | EP | disclosed |
| EP-0145368-A2 | Process for producing propylene block copolymers | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1985-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067651-A1 | PRODRUGS OF MYELOPEROXIDASE INHIBITORS | MPO, CAT, SOD1 | ALDH1A1 570/4885TSHR 2529/4885ADRB2 4561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.